Eu Ivdr Eu Ivd Class B On The Market

IDS PR3-II

Devices (same UDI-DI)
1
Certificates
0
Countries
32
Notified Bodies
0

Let the assistant research this device

The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.

Free to try · every answer cites its records

Basic Information

Primary DI
05060169695733
Basic UDI-DI Code
5060169694064XH
Reference
IS-AI1702II
Device Types
None provided
Regulation
Eu Ivdr
Classification
Eu Ivd Class B
Status
On The Market

Additional Description

The IDS PR3 II test is a chemiluminescent immunoassay (CLIA) for use on the IDS System for quantitative determination of the specific IgG antibodies directed against proteinase 3 (PR3) in samples of human serum or plasma (K3 EDTA, Sodium citrate). Results are to be used in conjunction with other clinical and laboratory data as an aid in the evaluation of ANCA-associated primitive systemic vasculitides and of Wegener’s granulomatosis (WG) in particular.

CND Nomenclature Codes

Code Description
W0102100403 PR3 ANCA

Available In Countries

🇦🇹 Austria 🇧🇪 Belgium 🇧🇬 Bulgaria 🇨🇾 Cyprus 🇨🇿 Czechia 🇩🇪 Germany 🇩🇰 Denmark 🇪🇪 Estonia 🇬🇷 Greece 🇪🇸 Spain 🇫🇮 Finland 🇫🇷 France 🇭🇷 Croatia 🇭🇺 Hungary 🇮🇪 Ireland 🇮🇸 Iceland 🇮🇹 Italy 🇱🇮 Liechtenstein 🇱🇹 Lithuania 🇱🇺 Luxembourg 🇱🇻 Latvia 🇲🇹 Malta 🇳🇱 Netherlands 🇳🇴 Norway 🇵🇱 Poland 🇵🇹 Portugal 🇷🇴 Romania 🇸🇪 Sweden 🇸🇮 Slovenia 🇸🇰 Slovakia 🇹🇷 Türkiye 🇬🇧 United Kingdom

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Class B) and regulation (EU IVDR).

View all